EGFR and Src are involved in indole-3-carbinol-induced death and cell cycle arrest of human breast cancer cells

Carcinogenesis

Volumn 28, Issue 2, 2007, Pages 435-445

  Moiseeva, Elena P ^a   Heukers, Raimond ^a   Manson, Margaret M ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; 4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; CYCLIN D1; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; PROTEIN TYROSINE KINASE; STAT1 PROTEIN; STAT3 PROTEIN; TYROSINE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RESISTANCE; CELL CYCLE ARREST; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE OVEREXPRESSION; GENETIC CODE; HUMAN; HUMAN CELL; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; HUMANS; INDOLES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RECEPTOR, EPIDERMAL GROWTH FACTOR; TYROSINE;

EID: 33847332146     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl171     Document Type: Article

References (57)

1. IARC Working Group on the Evaluation of Cancer Preventive Strategies. (ed.) (2004) Cruciferous Vegetables, Isothiocyanates and Indoles. IARC Handbooks on Cancer Prevention. IARC Press, Lyon, Vol. 9, pp. 1-246.
2. Bell,M.C., Crowley-Nowick,P., Bradlow,H.L., Sepkovic,D.W., Schmidt-Grimminger,D., Howell,P., Mayeaux,E.J., Tucker,A., Turbat-Herrera,E.A. and Mathis,J.M. (2000) Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol. Oncol., 78, 123-129.
3. Rosen,C.A. and Bryson,P.C. (2004) Indole-3-carbinol for recurrent respiratory papillomatosis: Long-term results. J. Voice, 18, 248-253.
4. Reed,G.A., Peterson,K.S., Smith,H.J., Gray,J.C., Sullivan,D.K., Mayo,M.S., Crowell,J.A. and Hurwitz,A. (2005) A phase I study of indole-3-carbinol in women: Tolerability and effects. Cancer Epidemiol. Biomarkers Prev., 14, 1953-1960.
5. Chen,D.Z., Qi,M., Auborn,K.J. and Carter,T.H. (2001) Indole-3-carbinol and diindolylmethane induce apoptosis of human cervical cancer cells and in murine HPV16-transgenic preneoplastic cervical epithelium. J. Nutr., 131, 3294-3302.
6. Zhang,X. and Malejka-Giganti,D. (2003) Effects of treatment of rats with indole-3-carbinol on apoptosis in the mammary gland and mammary adenocarcinomas. Anticancer Res., 23, 2473-2479.
7. Katdare,M., Singhal,H., Newmark,H., Osborne,M.P. and Telang,N.T. (1997) Prevention of mammary preneoplastic transformation by naturally-occurring tumor inhibitors. Cancer Lett., 111, 141-147.
8. Kim,Y.S. and Milner,J.A. (2005) Targets for indole-3-carbinol in cancer prevention. J. Nutr. Biochem., 16, 65-73.
9. Telang,N.T., Katdare,M., Bradlow,H.L., Osborne,M.P. and Fishman,J. (1997) Inhibition of proliferation and modulation of estradiol metabolism: Novel mechanisms for breast cancer prevention by the phytochemical indole-3-carbinol. Proc. Soc. Exp. Biol. Med., 216, 246-252.
10. Cover,C.M., Hsieh,S.J., Tran,S.H., Hallden,G., Kim,G.S., Bjeldanes,L.F. and Firestone,G.L. (1998) Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J. Biol. Chem., 273, 3838-3847.
11. Chinni,S.R., Li,Y., Upadhyay,S., Koppolu,P.K. and Sarkar,F.H. (2001) Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene, 20, 2927-2936.
12. Howells,L.M., Hudson,E.A. and Manson,M.M. (2005) Inhibition of phosphatidylinositol 3-kinase/protein kinase B signaling is not sufficient to account for indole-3-carbinol-induced apoptosis in some breast and prostate tumor cells. Clin. Cancer Res., 11, 8521-8527.
13. Cram,E.J., Liu,B.D., Bjeldanes,L.F. and Firestone,G.L. (2001) Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Sp1 transcription factor interactions with a composite element in the CDK6 gene promoter. J. Biol. Chem., 276, 22332-22340.
14. Zhang,J., Hsu,B.A.J., Kinseth,A.M., Bjeldanes,L.F. and Firestone,G.L. (2003) Indole-3-carbinol induces a G1 cell cycle arrest and inhibits prostate-specific antigen production in human LNCaP prostate carcinoma cells. Cancer, 98, 2511-2520.
15. Matsuzaki,Y., Koyama,M., Hitomi,T., Kawanaka,M. and Sakai,T. (2004) Indole-3-carbinol activates the cyclin-dependent kinase inhibitor p15(INK4b) gene. FEBS Lett., 576, 137-140.
16. Garcia,H.H., Brar,G.A., Nguyen,D.H., Bjeldanes,L.F. and Firestone,G.L. (2004) Indole-3-carbinol (I3C) inhibits cyclin dependent kinase-2 function in human breast cancer cells by regulating the size distribution, associated cyclin E forms and subcellular localization of the CDK2 protein complex. J. Biol. Chem., 280, 8756-8764.
17. Brew,C.T., Aronchik,I., Hsu,J.C., Sheen,J.H., Dickson,R.B., Bjeldanes,L.F. and Firestone,G.L. (2006) Indole-3-carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells. Int. J. Cancer, 118, 857-868.
18. Chinni,S.R. and Sarkar,F.H. (2002) Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Clin. Cancer Res., 8, 1228-1236.
19. Howells,L.M., Gallacher-Horley,B., Houghton,C.E., Manson,M.M. and Hudson,E.A. (2002) Indole-3-carbinol inhibits protein kinase B/Akt and induces apoptosis in the human breast tumor cell line MDA MB468 but not in the nontumorigenic HBL100 line. Mol. Cancer Ther., 1, 1161-1172.
20. Rahman,K.M., Li,Y. and Sarkar,F.H. (2004) Inactivation of akt and NF-kappaB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells. Nutr. Cancer, 48, 84-94.
21. Moiseeva,E.P., Fox,L.H., Howells,L.M., Temple,L.A.F. and Manson,M.M. (2006) Indole-3-carbinol-induced death in cancer cells involves EGFR downregulation and is exacerbated in a 3D environment. Apoptosis, 11, 799-812.
22. Biscardi,J.S., Maa,M.C., Tice,D.A., Cox,M.E., Leu,T.H. and Parsons,S.J. (1999) c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J. Biol. Chem., 274, 8335-8343.
23. Sato,K., Nagao,T., Iwasaki,T., Nishihira,Y. and Fukami,Y. (2003) Src-dependent phosphorylation of the EGF receptor Tyr-845 mediates Stat-p21waf1 pathway in A431 cells. Genes Cells, 8, 995-1003.
24. Gordon,L.A., Mulligan,K.T., Maxwell-Jones,H., Adams,M., Walker,R.A. and Jones,J.L. (2003) Breast cell invasive potential relates to the myoepithelial phenotype. Int. J. Cancer, 106, 8-16.
25. Fang,M.Z., Chen,D., Sun,Y., Jin,Z., Christman,J.K. and Yang,C.S. (2005) Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin. Cancer Res., 11, 7033-7041.
26. Avizienyte,E., Wyke,A.W., Jones,R.J., McLean,G.W., Westhoff,M.A., Brunton,V.G. and Frame,M.C. (2002) Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nat. Cell. Biol., 4, 632-638.
27. Fasco,M.J., Keyomarsi,K., Arcaro,K.F. and Gierthy,J.F. (2000) Expression of an estrogen receptor alpha variant protein in cell lines and tumors. Mol. Cell. Endocrinol., 166, 156-169.
28. Sorlie,T. (2004) Molecular portraits of breast cancer: Tumour subtypes as distinct disease entities. Eur. J. Cancer, 40, 2667-2675.
29. Bertucci,F., Finetti,P., Rougemont,J. et al. (2005) Gene expression profiling identifies molecular subtypes of inflammatory breast cancer. Cancer Res., 65, 2170-2178.
30. Shaw,J.A., Udokang,K., Mosquera,J.M., Chauhan,H., Jones,J.L. and Walker,R.A. (2002) Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas. J. Pathol., 198, 450-457.
31. Nielsen,T.O., Hsu,F.D., Jensen,K et al. (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin. Cancer Res., 10, 5367-5374.
32. Akhand,A.A., Pu,M., Senga,T., Kato,M., Suzuki,H., Miyata,T., Hamaguchi,M. and Nakashima,I. (1999) Nitric oxide controls src kinase activity through a sulfhydryl group modification-mediated Tyr-527-independent and Tyr-416-linked mechanism. J. Biol. Chem., 274, 25821-25826.
33. Ettenberg,S.A., Rubinstein,Y.R., Banerjee,P., Nau,M.M., Keane,M.M. and Lipkowitz,S. (1999) cbl-b inhibits EGF-receptor-induced apoptosis by enhancing ubiquitination and degradation of activated receptors. Mol. Cell. Biol. Res. Commun., 2, 111-118.
34. Garcia,R., Bowman,T.L., Niu,G. et al. (2001) Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene, 20, 2499-2513.
35. Kloth,M.T., Laughlin,K.K., Biscardi,J.S., Boerner,J.L., Parsons,S.J. and Silva,C.M. (2003) STAT5b, a mediator of synergism between c-Src and the epidermal growth factor receptor. J. Biol. Chem., 278, 1671-1679.
36. Biscardi,J.S., Belsches,A.P. and Parsons,S.J. (1998) Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells. Mol. Carcinog., 21, 261-272.
37. Osusky,M., Taylor,S.J. and Shalloway,D. (1995) Autophosphorylation of purified c-Src at its primary negative regulation site. J. Biol. Chem., 270, 25729-25732.
38. Frame,M.C. (2002) Src in cancer: Deregulation and consequences for cell behaviour. Biochim. Biophys. Acta, 1602, 114-130.
39. Gartel,A.L. and Tyner,A.L. (2002) The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol. Cancer Ther., 1, 639-649.
40. Ashok,B.T., Chen,Y.G., Liu,X, Garikapaty,V.P., Seplowitz,R., Tschorn,J., Roy,K., Mittelman,A. and Tiwari,R.K. (2002) Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer. Eur. J. Cancer Prev., 11, S86-S93.
41. Cunliffe,H.E., Ringner,M., Bilke,S., Walker,R.L., Cheung,J.M., Chen,Y. and Meltzer,P.S. (2003) The gene expression response of breast cancer to growth regulators: Patterns and correlation with tumor expression profiles. Cancer Res., 63, 7158-7166.
42. Bianco,R., Shin,I., Ritter,C.A., Yakes,F.M., Basso,A., Rosen,N., Tsurutani,J., Dennis,P.A., Mills,G.B. and Arteaga,C.L. (2003) Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors. Oncogene, 22, 2812-2822.
43. Okubo,S., Kurebayashi,J., Otsuki,T., Yamamoto,Y., Tanaka,K. and Sonoo,H. (2004) Additive antitumour effect of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa, ZD1839) and the antioestrogen fulvestrant (Faslodex, ICI 182,780) in breast cancer cells. Br. J. Cancer, 90, 236-244.
44. Bao,J., Gur,G. and Yarden,Y. (2003) Src promotes destruction of c-Cb1: implications for oncogenic synergy between Src and growth factor receptors. Proc. Natl Acad. Sci. USA, 100, 2438-2443.
45. Manson,M.M., Hudson,E.A., Ball,H.W., Barrett,M.C., Clark,H.L., Judah,D.J., Verschoyle,R.D. and Neal,G.E. (1998) Chemoprevention of aflatoxin B1-induced carcinogenesis by indole-3-carbinol in rat liver - predicting the outcome using early biomarkers. Carcinogenesis, 19, 1829-1836.
46. Chatterji,U., Riby,J.E., Taniguchi,T., Bjeldanes,E.L., Bjeldanes,L.F. and Firestone,G.L. (2004) Indole-3-carbinol stimulates transcription of the interferon gamma receptor 1 gene and augments interferon responsiveness in human breast cancer cells. Carcinogenesis, 25, 1119-1128.
47. Ishizawar,R. and Parsons,S.J. (2004) c-Src and cooperating partners in human cancer. Cancer Cell, 6, 209-214.
48. Cabodi,S., Moro,L., Baj,G. et al. (2004) p130Cas interacts with estrogen receptor alpha and modulates non-genomic estrogen signaling in breast cancer cells. J. Cell. Sci., 117, 1603-1611.
49. Laskin,J.J. and Sandler,A.B. (2004) Epidermal growth factor receptor: A promising target in solid tumours. Cancer Treat Rev., 30, 1-17.
50. Bild,A.H., Yao,G., Chang,J.T. et al. (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature, 439, 353-357.
51. Furstoss,O., Manes,G. and Roche,S. (2002) Cyclin E and cyclin A are likely targets of Src for PDGF-induced DNA synthesis in fibroblasts. FEBS Lett., 526, 82-86.
52. Lo,H.W. and Hung,M.C. (2006) Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. Br. J. Cancer, 94, 184-188.
53. Armstrong,D.K., Kaufmann,S.H., Ottaviano,Y.L., Furuya,Y., Buckley,J.A., Isaacs,J.T. and Davidson,N.E. (1994) Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells. Cancer Res., 54, 5280-5283.
54. Fan,Z., Lu,Y., Wu,X., DeBlasio,A., Koff,A. and Mendelsohn,J. (1995) Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition. J. Cell. Biol., 131, 235-242.
55. Chin,Y.E., Kitagawa,M., Kuida,K., Flavell,R.A. and Fu,X.Y. (1997) Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol. Cell. Biol., 17, 5328-5337.
56. Kumar,R.R., Meenakshi,A. and Sivakumar,N. (2001) Enzyme immunoassay of human epidermal growth factor receptor (hEGFR). Hum. Antibodies, 10, 143-147.
57. Tidow,N., Boecker,A., Schmidt,H., Agelopoulos,K,. Boecker,W., Buerger,H. and Brandt,B. (2003) Distinct amplification of an untranslated regulatory sequence in the egfr gene contributes to early steps in breast cancer development. Cancer Res., 63, 1172-1178.